DRD1 and schizophrenia: Preclinical and clinical studies had shown that l-SPD could relieve both positive and negative symptoms of schizophrenia mediated by D2R antagonism in the nucleus accumbens (NAc) and D1R agonism in the mPFC, respectively20, 24.